SOUTH KOREA · OPENDART
IntoCell, Inc.
인투셀 · 287840 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
No exchange purchase by an insider is on record yet.
Other changes in holdings · 10
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-06-04 | Lee Hyang Sook | Senior managing director | Others(+) | 7,428 | DART ↗ |
| 2026-06-04 | Kim Sun Young | Managing director | Others(+) | 7,092 | DART ↗ |
| 2026-02-02 | Suh Young Suk | Vice president | Stock options(+) | 1,060 | DART ↗ |
| 2025-12-24 | Suh Young Suk | Senior managing director | Stock options(+) | 3,300 | DART ↗ |
| 2025-05-23 | Choi Jae Hee | Director | New listing(+) | 40,400 | DART ↗ |
| 2025-05-23 | Kim Sun Young | Director | New listing(+) | 207,960 | DART ↗ |
| 2025-05-23 | Lee Hyang Sook | Managing director | New listing(+) | 285,040 | DART ↗ |
| 2025-05-23 | Suh Young Suk | Senior managing director | New listing(+) | 76,400 | DART ↗ |
| 2025-05-23 | Rew Yosup | Vice president | New listing(+) | 144,000 | DART ↗ |
| 2025-05-23 | Park Tae Kyo | CEO | New listing(+) | 2,900,000 | DART ↗ |